| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.5M | +259.6% |
| SG&A Expense | $12.7M | +9124.3% |
| Operating Income | -$16.7M | -340.9% |
| Interest Expense | $6.3M | — |
| Net Income | $9.0M | +607.5% |
| EPS (Basic) | $1.07 | +864.3% |
| EPS (Diluted) | $0.75 | +635.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $343K | +1716.1% |
| Inventory | $243K | — |
| Current Assets | $1.2M | +940.2% |
| Total Assets | $1.4M | -94.4% |
| Current Liabilities | $26.5M | +716.1% |
| Total Liabilities | $28.6M | +153.4% |
| Stockholders' Equity | -$27.2M | -145.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.4M | -778.9% |
| Capital Expenditures | $70K | +782.9% |
| Investing Cash Flow | -$25K | -100.0% |
| Financing Cash Flow | $7.7M | +103.7% |
| Free Cash Flow | -$7.4M | -778.9% |